Keywords: Recordati, OTC portfolio, Russia, Akvion

Recordati acquires a portfolio of OTC products in Russia

Article | 16 October 2012

Print This

Italian drugmaker Recordati (RC: MI) yesterday announced the signing of agreements covering the acquisition of all rights to five product ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in